Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 325 of 591 entries
View as:

Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT06498973 Org: User:
Start: 01/28/25 End: 04/25/27 Due: 04/25/28

Epcoritamab and Tazemetostat for the Treatment of Relapsed or Refractory Grade I-IIIa Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06575686 Org: User:
Start: 03/11/25 End: 07/16/28 Due: 07/16/29

e-Health Intervention (Day-by-Day) for the Management of Fear of Progression in Women With Stage III or IV Gynecologic Cancer: A Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT05786456 Org: User:
Start: 07/19/24 End: 06/20/25 Due: 06/20/26

Long Term Follow-Up in Patients With Stage 0-IIIC Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04661982 Org: User:
Start: 07/06/10 End: 11/20/25 Due: 11/20/26

Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT06575296 Org: User:
Start: 12/06/24 End: 04/29/28 Due: 04/29/29

High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT03128359 Org: User:
Start: 05/30/17 End: 09/15/21 Due: 09/15/22

CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT05672147 Org: User:
Start: 12/07/23 End: 09/03/28 Due: 09/03/29

Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05830058 Org: User:
Start: 11/29/23 End: 02/03/27 Due: 02/03/28

Technology-Enabled Activation of Skin Cancer Screening for Stem Cell Transplant Survivors and Their Primary Care Providers, TEACH Study

Phase: N/A Priority: Normal
NCT ID: NCT04358276 Org: User:
Start: 10/30/20 End: 03/31/26 Due: 03/31/27

Dasatinib in Treating Patients With Stage IV Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00544908 Org: User:
Start: 09/30/07 End: - Due: -

Cancer Pain Rehabilitation Program to Reduce Pain Related Distress, and Reliance of Pain Medication Through Multimodal Nonpharmacological Solutions

Phase: N/A Priority: Normal
NCT ID: NCT05036408 Org: User:
Start: 07/21/21 End: 05/06/24 Due: 05/06/25

Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003042 Org: User:
Start: 05/30/97 End: 12/29/25 Due: 12/29/26

Mindful Movement Program in Improving Quality of Life in Older Female Breast Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT00903474 Org: User:
Start: 08/31/08 End: 04/30/10 Due: 04/30/11

Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer After Undergoing Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01923506 Org: User:
Start: 11/25/13 End: 08/27/25 Due: 08/27/26

68Ga-PSMA-11 PET for the Diagnosis of Biochemically Recurrent Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04216134 Org: User:
Start: 12/12/19 End: 12/09/22 Due: 12/09/23

Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02432963 Org: User:
Start: 06/14/16 End: 10/31/25 Due: 10/31/26

Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT04681105 Org: User:
Start: 11/18/20 End: 05/05/26 Due: 05/05/27

Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease

Phase: N/A Priority: Normal
NCT ID: NCT00813878 Org: User:
Start: 07/31/01 End: 09/30/12 Due: 09/30/13

Study of Support Groups for African-American Breast Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT00949871 Org: User:
Start: 01/31/08 End: 09/30/09 Due: 09/30/10

A Mobile Application, Oncpatient, to Assist Patients Undergoing Radiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05173961 Org: User:
Start: 06/29/22 End: 06/22/25 Due: 06/22/26

Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03361735 Org: User:
Start: 08/29/18 End: 02/04/26 Due: 02/04/27

IRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03918499 Org: User:
Start: 04/19/19 End: 02/09/23 Due: 02/09/24

Remotivation Process for Improving Adherence to Lymphedema Treatment Programs in Patients With Breast Cancer-Related Lymphedema

Phase: N/A Priority: Normal
NCT ID: NCT04465253 Org: User:
Start: 04/19/19 End: 06/21/22 Due: 06/21/23

Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04362839 Org: User:
Start: 05/27/20 End: 09/13/25 Due: 09/13/26

Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04913064 Org: User:
Start: 07/27/21 End: 01/12/26 Due: 01/12/27